Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
Search within:  

Sort results by:      



Filter results by:

1-13 of 13  
 
2.  
Alemtuzumab for treating relapsing–remitting multiple sclerosis. 2014 May. NGC:010430
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
5.  
Teriflunomide for treating relapsing–remitting multiple sclerosis. 2014 Jan. NGC:010284
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6.  
Recommendations for drug therapies for relapsing-remitting multiple sclerosis. 2013 Oct. NGC:010418
Canadian Agency for Drugs and Technologies in Health - Nonprofit Organization. View all guidelines by the developer(s)
7.  
Fingolimod for the treatment of highly active relapsing-remitting multiple sclerosis. 2012 Apr. NGC:009075
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
8.  
Dementia in the long term care setting. 1998 (revised 2012). NGC:009847
American Medical Directors Association - Professional Association. View all guidelines by the developer(s)
10.  
Nursing management of the patient with multiple sclerosis. 2011. NGC:009286
American Association of Neuroscience Nurses - Professional Association; Association of Rehabilitation Nurses - Professional Association; International Organization of Multiple Sclerosis Nurses - Professional Association. View all guidelines by the developer(s)
11.  
Use of imaging in multiple sclerosis. 2006 Apr (revised 2011). NGC:008784
European Federation of Neurological Societies - Medical Specialty Society. View all guidelines by the developer(s)
13.  
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. 2006 Nov (revised 2010 Sep). NGC:008162
European Federation of Neurological Societies - Medical Specialty Society. View all guidelines by the developer(s)
1-13 of 13